PBM Capital Group
PBM Capital Group is a private investment firm primarily focused on healthcare investments.
Business Model:
Revenue: $17.4M
Employees: 11-50
Rankings
Industries / Tags:
Detailed PBM Capital Group Information
Geographic Data
Address: 200 Garrett St
City: Charlottesville
State: VA
Zip: 22902
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare investments. Led by Paul Manning, a successful entrepreneur, it invests across all stages of corporate development– including venture capital, leveraged buyouts, growth capital, distressed/turnaround, and public equity value investing– and create value by applying extensive industry knowledge and contacts, providing superior operational expertise and bringing an entrepreneurial spirit to attractive investment opportunities. We actively partner with our portfolio companies to drive commercial success and enhance profitability.
Contact Phone:
+14349808100
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2021 | Xalud Therapeutics | Series C | 0 |
| 5/2019 | ArcherDX | Series B | 60M |
| 9/2021 | LEXEO Therapeutics | Series B | 0 |
| 2/2021 | PatientsLikeMe | Venture Round | 0 |
| 1/2021 | LEXEO Therapeutics | Series A | 0 |
| 12/2019 | ArcherDX | Series C | 0 |
| 10/2018 | Acumen Pharmaceuticals | Series A | 15M |
| 4/2020 | Atsena Therapeutics | Venture Round | 8.2M |
| 1/2019 | Candel Therapeutics | Series B | 28.7M |
| 5/2021 | Genapsys | Series D | 0 |
| 2/2021 | SalioGen Therapeutics | Series A | 0 |
| 8/2019 | Landos Biopharma | Series B | 60M |
| 9/2018 | Nanoview Biosciences | Series B | 10M |
| 7/2020 | Verona Pharma | Private Placement | 200M |
| 3/2018 | ArcherDX | Series A | 35M |
| 4/2020 | Taysha Gene Therapies | Seed Round | 0 |
| 11/2020 | Acumen Pharmaceuticals | Series B | 0 |
| 8/2020 | Taysha Gene Therapies | Series B | 0 |
| 9/2021 | LEXEO Therapeutics | Series B | 0 |
| 8/2021 | Xalud Therapeutics | Series C | 0 |
| 5/2021 | Genapsys | Series D | 0 |
| 2/2021 | SalioGen Therapeutics | Series A | 0 |
| 2/2021 | PatientsLikeMe | Venture Round | 0 |
| 1/2021 | LEXEO Therapeutics | Series A | 0 |
| 11/2020 | Acumen Pharmaceuticals | Series B | 0 |
| 8/2020 | Taysha Gene Therapies | Series B | 0 |
| 7/2020 | Verona Pharma | Post-IPO Equity | 0 |
| 4/2020 | Taysha Gene Therapies | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
